Fax: (212) 678-4125
Article first published online: 3 DEC 2008
Copyright © 2008 American Cancer Society
Supplement: Cancer and Aging: Challenges and Opportunities across the Cancer Control Continuum
Volume 113, Issue Supplement 12, pages 3493–3504, 15 December 2008
How to Cite
Sheinfeld Gorin, S., Gauthier, J., Hay, J., Miles, A. and Wardle, J. (2008), Cancer screening and aging: Research barriers and opportunities. Cancer, 113: 3493–3504. doi: 10.1002/cncr.23938
Sponsored by the National Cancer Institute's Office of Cancer Survivorship.
Presented at the Society of Behavioral Medicine pre-conference entitled “Cancer and Aging: Challenges and Opportunities across the Cancer Control Continuum,” Washington, DC, March 21, 2007.
- Issue published online: 3 DEC 2008
- Article first published online: 3 DEC 2008
- Manuscript Accepted: 14 APR 2008
- Manuscript Revised: 7 APR 2008
- Manuscript Received: 7 NOV 2007
- cancer screening;
- research agenda;
Cancer is the second most common cause of death among those aged ≥65 years, and is a major cause of morbidity. There is some evidence that screening, by detecting precancerous lesions in asymptomatic patients, is effective in reducing cancer-related morbidity and mortality among older men and women. The objectives of the current review article were to identify some of the barriers to and opportunities for research in cancer screening among older individuals. Using expert opinion, the authors developed a taxonomy of barriers to research among those aged ≥65 years at 3 levels: the macro (policy and population), the organizational and provider, and the interindividual and intraindividual. There are numerous barriers to high-quality screening research among older individuals, across all 3 levels of the taxonomy. Overall, there are limited evaluations of repeat adherence; follow-up for positive findings; screening, diagnostic, and treatment delays; and access to and acceptance of screening among those aged ≥65 years. There are particular barriers to research in colorectal cancer screening. There has been limited development and testing of evidence-based and theory-based intervention approaches to enrich screening adherence over time by those aged ≥65 years in which screening has demonstrated effectiveness. Professional groups differ in their recommendations for screening older asymptomatic patients, and implementation varies across healthcare systems in the US and the UK. The authors propose an agenda for cancer screening research in older populations, based on US and UK experiences. Cancer 2008;113(12 suppl):3493–504. © 2008 American Cancer Society.